Suppr超能文献

ADAMTS 生物标志物的研究进展。

Advances in ADAMTS biomarkers.

机构信息

Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, United States.

出版信息

Adv Clin Chem. 2022;106:1-32. doi: 10.1016/bs.acc.2021.09.002. Epub 2021 Nov 27.

Abstract

A Disintegrin and Metalloproteinase with Thrombospondin motifs (ADAMTS) are major mediators in extracellular matrix (ECM) turnover and have gained increasing interest over the last years as major players in ECM remodeling during tissue homeostasis and the development of diseases. Although, ADAMTSs are recognized in playing important roles during tissue remodeling, and loss of function in various member of the ADAMTS family could be associated with the development of numerous diseases, limited knowledge is available about their specific substrates and mechanism of action. In this chapter, we will review current knowledge about ADAMTSs and their use as disease biomarkers.

摘要

解整合素金属蛋白酶与凝血酶敏感蛋白基元(ADAMTS)是细胞外基质(ECM)代谢的主要介质,近年来,它们作为组织稳态和疾病发展过程中 ECM 重塑的主要参与者,引起了越来越多的关注。尽管 ADAMTS 在组织重塑中发挥着重要作用,而且 ADAMTS 家族的各种成员的功能丧失可能与许多疾病的发展有关,但关于它们的特定底物和作用机制的知识有限。在本章中,我们将回顾 ADAMTS 的现有知识及其作为疾病生物标志物的应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验